BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25151961)

  • 1. Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival.
    Lopes MH; Santos TG; Rodrigues BR; Queiroz-Hazarbassanov N; Cunha IW; Wasilewska-Sampaio AP; Costa-Silva B; Marchi FA; Bleggi-Torres LF; Sanematsu PI; Suzuki SH; Oba-Shinjo SM; Marie SK; Toulmin E; Hill AF; Martins VR
    Oncogene; 2015 Jun; 34(25):3305-14. PubMed ID: 25151961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.
    Zhai E; Liang W; Lin Y; Huang L; He X; Cai S; Chen J; Zhang N; Li J; Zhang Q; He Y; Zeng Z; Chen M; Xu L; Peng S
    Cell Physiol Biochem; 2018; 47(2):879-892. PubMed ID: 29843139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells.
    de Lacerda TC; Costa-Silva B; Giudice FS; Dias MV; de Oliveira GP; Teixeira BL; Dos Santos TG; Martins VR
    Clin Exp Metastasis; 2016 Jun; 33(5):441-51. PubMed ID: 27112151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting prion protein interactions in cancer.
    Santos TG; Lopes MH; Martins VR
    Prion; 2015; 9(3):165-73. PubMed ID: 26110608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-canonical Hop protein from Caenorhabditis elegans exerts essential functions and forms binary complexes with either Hsc70 or Hsp90.
    Gaiser AM; Brandt F; Richter K
    J Mol Biol; 2009 Aug; 391(3):621-34. PubMed ID: 19559711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.
    Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B
    Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.
    Walsh N; Larkin A; Swan N; Conlon K; Dowling P; McDermott R; Clynes M
    Cancer Lett; 2011 Jul; 306(2):180-9. PubMed ID: 21470770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1.
    Romano SA; Cordeiro Y; Lima LM; Lopes MH; Silva JL; Foguel D; Linden R
    FASEB J; 2009 Dec; 23(12):4308-16. PubMed ID: 19703931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum Hop: detailed analysis on complex formation with Hsp70 and Hsp90.
    Hatherley R; Clitheroe CL; Faya N; Tastan Bishop Ö
    Biochem Biophys Res Commun; 2015 Jan; 456(1):440-5. PubMed ID: 25482441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a plant homolog of hop, a cochaperone of hsp90.
    Zhang Z; Quick MK; Kanelakis KC; Gijzen M; Krishna P
    Plant Physiol; 2003 Feb; 131(2):525-35. PubMed ID: 12586877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells.
    Fonseca AC; Romão L; Amaral RF; Assad Kahn S; Lobo D; Martins S; Marcondes de Souza J; Moura-Neto V; Lima FR
    Neuroscience; 2012 Jan; 200():130-41. PubMed ID: 22062133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain:domain interactions within Hop, the Hsp70/Hsp90 organizing protein, are required for protein stability and structure.
    Carrigan PE; Sikkink LA; Smith DF; Ramirez-Alvarado M
    Protein Sci; 2006 Mar; 15(3):522-32. PubMed ID: 16452615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional coevolutionary networks of the Hsp70-Hop-Hsp90 system revealed through computational analyses.
    Travers SA; Fares MA
    Mol Biol Evol; 2007 Apr; 24(4):1032-44. PubMed ID: 17267421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas.
    Boccacino JM; Dos Santos Peixoto R; Fernandes CFL; Cangiano G; Sola PR; Coelho BP; Prado MB; Melo-Escobar MI; de Sousa BP; Ayyadhury S; Bader GD; Shinjo SMO; Marie SKN; da Rocha EL; Lopes MH
    BMC Cancer; 2024 Feb; 24(1):199. PubMed ID: 38347462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
    Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp70/Hsp90 organising protein (hop): beyond interactions with chaperones and prion proteins.
    Baindur-Hudson S; Edkins AL; Blatch GL
    Subcell Biochem; 2015; 78():69-90. PubMed ID: 25487016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of the substrate transfer mechanism in Hsp70/Hsp90 folding machinery mediated by Hop.
    Alvira S; Cuéllar J; Röhl A; Yamamoto S; Itoh H; Alfonso C; Rivas G; Buchner J; Valpuesta JM
    Nat Commun; 2014 Nov; 5():5484. PubMed ID: 25407331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
    Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
    J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
    J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.